Delivery Order SPE2DB22D3301-SPE2DB26FX3FR
Award Date 10/8/25
Potential Completion Date 10/30/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1.34 million delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Revlimid 10 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive process and scheduled for completion by October 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Revlimid 10 mg capsules (100-count units) with a ceiling value of $52,575.49. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Revlimid 25 mg capsules (100 count) with a ceiling value of $104,975.62. This firm fixed-price delivery order, which is expected to be completed by October 15, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Revlimid 10 mg capsules (28-count packaging) under a firm fixed price contract valued at $25,840.56. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 28, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger indefinite...
- The Defense Logistics Agency awarded a $12,920.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 count) on October 8, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $147,872 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 25 mg capsules (100-count units) under a firm fixed-price contract valued at $52,487.80, with completion expected by September 26, 2025. This non-competitive delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $52,575.49 and an ultimate completion date of September 26, 2025. This is a competitively awarded, non-set-aside delivery order issued to support federal medical procurement needs. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,879.46 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Revlimid 5 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025, and performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...